Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.
Meda Pharmaceuticals specializes in respiratory, allergy, central nervous system, and cough-cold products.
September 2009:
MEDA introduces EDLUAR™, the first and only sublingual tablet that contains the most prescribed sleep medication, zolpidem tartrate »
September 2009:
MEDA receives FDA approval of new ASTEPRO® (azelastine HCl) nasal spray 0.15%, the first and only once-daily nasal antihistamine »
June 2009:
FDA approval for Onsolis anticipated during summer 2009 »
Meda Pharmaceutical's Philosophy »
Click here to view our Career Opportunities »
Meda Pharmaceutical Inc. supports bona fide educational programs through the provision of educational grants.
Privacy Policy
